Progress in rheumatology: Understanding autoimmune disease

Robert (Rob) Bennett

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Fifty years ago, Wegener's granulomatosis was a uniformly fatal condition; the diagnosis was usually made post-mortem. Today, many patients survive, with a 93% complete remission rate reported 4 years after diagnosis. Four medical advances over the past 50 years have enhanced our understanding and management of this rheumatologic disorder. They are a rational classification of the vasculitides, development of a diagnostically useful serologic assay, successful treatment with cyclophosphamide, and novel ideas as to etiology.

    Original languageEnglish (US)
    Pages (from-to)44-51
    Number of pages8
    JournalGeriatrics
    Volume51
    Issue number1
    StatePublished - Jan 1996

    Fingerprint

    Rheumatology
    Autoimmune Diseases
    Granulomatosis with Polyangiitis
    Vasculitis
    Cyclophosphamide
    Therapeutics

    ASJC Scopus subject areas

    • Geriatrics and Gerontology

    Cite this

    Progress in rheumatology : Understanding autoimmune disease. / Bennett, Robert (Rob).

    In: Geriatrics, Vol. 51, No. 1, 01.1996, p. 44-51.

    Research output: Contribution to journalArticle

    Bennett, RR 1996, 'Progress in rheumatology: Understanding autoimmune disease', Geriatrics, vol. 51, no. 1, pp. 44-51.
    Bennett, Robert (Rob). / Progress in rheumatology : Understanding autoimmune disease. In: Geriatrics. 1996 ; Vol. 51, No. 1. pp. 44-51.
    @article{2ee53bd172c54cccb8c7dfb0f0f77713,
    title = "Progress in rheumatology: Understanding autoimmune disease",
    abstract = "Fifty years ago, Wegener's granulomatosis was a uniformly fatal condition; the diagnosis was usually made post-mortem. Today, many patients survive, with a 93{\%} complete remission rate reported 4 years after diagnosis. Four medical advances over the past 50 years have enhanced our understanding and management of this rheumatologic disorder. They are a rational classification of the vasculitides, development of a diagnostically useful serologic assay, successful treatment with cyclophosphamide, and novel ideas as to etiology.",
    author = "Bennett, {Robert (Rob)}",
    year = "1996",
    month = "1",
    language = "English (US)",
    volume = "51",
    pages = "44--51",
    journal = "Geriatrics",
    issn = "0016-867X",
    publisher = "Advanstar Communications",
    number = "1",

    }

    TY - JOUR

    T1 - Progress in rheumatology

    T2 - Understanding autoimmune disease

    AU - Bennett, Robert (Rob)

    PY - 1996/1

    Y1 - 1996/1

    N2 - Fifty years ago, Wegener's granulomatosis was a uniformly fatal condition; the diagnosis was usually made post-mortem. Today, many patients survive, with a 93% complete remission rate reported 4 years after diagnosis. Four medical advances over the past 50 years have enhanced our understanding and management of this rheumatologic disorder. They are a rational classification of the vasculitides, development of a diagnostically useful serologic assay, successful treatment with cyclophosphamide, and novel ideas as to etiology.

    AB - Fifty years ago, Wegener's granulomatosis was a uniformly fatal condition; the diagnosis was usually made post-mortem. Today, many patients survive, with a 93% complete remission rate reported 4 years after diagnosis. Four medical advances over the past 50 years have enhanced our understanding and management of this rheumatologic disorder. They are a rational classification of the vasculitides, development of a diagnostically useful serologic assay, successful treatment with cyclophosphamide, and novel ideas as to etiology.

    UR - http://www.scopus.com/inward/record.url?scp=0030046444&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0030046444&partnerID=8YFLogxK

    M3 - Article

    C2 - 8543198

    AN - SCOPUS:0030046444

    VL - 51

    SP - 44

    EP - 51

    JO - Geriatrics

    JF - Geriatrics

    SN - 0016-867X

    IS - 1

    ER -